Search research articles
Contact Us
Filters
Showing results (211-220 of 257) with videos related to
Page
of 26
Sort By:
Pathology
|
December 5, 1998
South Australian Scleroderma Register: analysis of deceased patients
C Bond, K D Pile, J D McNeil, et al.
The Journal of Rheumatology
|
December 17, 2003
Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis
Tania N Crotti, Michael J Ahern, Kylie Lange, et al.
Australian and New Zealand Journal of Medicine
|
August 1, 1986
Adult onset Still's disease or coxsackie polyarthritis?
P J Roberts-Thomson, T R Southwood, B W Moore, et al.
International Journal of Rheumatic Diseases
|
February 14, 2012
South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome
Scott W Graf, Paul Hakendorf, Sue Lester, et al.
Diabetologia
|
July 1, 1980
Improved glucose tolerance four hours after taking guar with glucose
D J Jenkins, T M Wolever, R Nineham, et al.
Journal of Substance Abuse
|
September 8, 2001
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
M Latka, J Ahern, R S Garfein, et al.
Internal Medicine Journal
|
January 26, 2005
Isolated pulmonary hypertension in scleroderma
S R Cox, J G Walker, M Coleman, et al.
Pathology
|
September 24, 2005
Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis
Jennifer G Walker, John Stirling, Dimitra Beroukas, et al.
Annals of the Rheumatic Diseases
|
November 14, 2002
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis
T N Crotti, M D Smith, H Weedon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 31, 2017
In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation
Carol A McCarthy, Waleed Faisal, Joseph P O'Shea, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 257) with videos related to
Sort By:
Page
of 26
Pathology
|
December 5, 1998
South Australian Scleroderma Register: analysis of deceased patients
C Bond, K D Pile, J D McNeil, et al.
The Journal of Rheumatology
|
December 17, 2003
Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis
Tania N Crotti, Michael J Ahern, Kylie Lange, et al.
Australian and New Zealand Journal of Medicine
|
August 1, 1986
Adult onset Still's disease or coxsackie polyarthritis?
P J Roberts-Thomson, T R Southwood, B W Moore, et al.
International Journal of Rheumatic Diseases
|
February 14, 2012
South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome
Scott W Graf, Paul Hakendorf, Sue Lester, et al.
Diabetologia
|
July 1, 1980
Improved glucose tolerance four hours after taking guar with glucose
D J Jenkins, T M Wolever, R Nineham, et al.
Journal of Substance Abuse
|
September 8, 2001
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
M Latka, J Ahern, R S Garfein, et al.
Internal Medicine Journal
|
January 26, 2005
Isolated pulmonary hypertension in scleroderma
S R Cox, J G Walker, M Coleman, et al.
Pathology
|
September 24, 2005
Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis
Jennifer G Walker, John Stirling, Dimitra Beroukas, et al.
Annals of the Rheumatic Diseases
|
November 14, 2002
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis
T N Crotti, M D Smith, H Weedon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 31, 2017
In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation
Carol A McCarthy, Waleed Faisal, Joseph P O'Shea, et al.
Page
of 26